Design, synthesis, molecular docking, biological evaluations and QSAR studies of novel dichloroacetate analogues as anticancer agent
作者:Masood Fereidoonnezhad、S. Mohammad Hossein Tabaei、Amirhossein Sakhteman、Hassan Seradj、Zeinab Faghih、Zahra Faghih、Ayyub Mojaddami、Batool Sadeghian、Zahra Rezaei
DOI:10.1016/j.molstruc.2020.128689
日期:2020.12
its proliferation. In this study, a series of novel N-aryl-2,2-dichloroacetamide and aryl-2,2-dichloroacetate derivatives were designed and synthesized. Their cytotoxic activities against various human cancer cell lines including A549, HCA-7, MCF-7, MDA-MB-231, KB and SKOV3 were evaluated. These compounds showed satisfactory potencies with much higher anticancer activity than the parent compound DCA
摘要 二氯乙酸 (DCA) 作为线粒体靶向小分子,通过抑制丙酮酸脱氢酶激酶 (PDK1-4),促进线粒体调节的细胞凋亡,从而抑制肿瘤生长并减少其增殖。在本研究中,设计并合成了一系列新型 N-芳基-2,2-二氯乙酰胺和芳基-2,2-二氯乙酸衍生物。评估了它们对各种人类癌细胞系(包括 A549、HCA-7、MCF-7、MDA-MB-231、KB 和 SKOV3)的细胞毒活性。与母体化合物 DCA 相比,这些化合物显示出令人满意的抗癌活性,对研究的癌细胞系具有更高的抗癌活性。还进行了分子对接研究以发现它们的结合位点以及它们与 PDK 同工酶的相互作用类型。在合成的化合物中,2,2-二氯-N-(9,10-dioxo-9, 10-dihydroanthracen-1-yl)acetamide (f1) 也可以诱导 A549 细胞凋亡。因此,化合物 f1 可能具有进一步研究药物开发的潜在价值。还使用一系列化学计量学方法探索了此类化合物的